Approval · Notice of Compliance 20730 · 2018
FUCIBET: Notice of Compliance 20730
Issued April 12, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20730
- Date
- April 12, 2018
- Company
- Leo Pharma IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FUCIBET | 02474883 | Marketed |
Medicinal ingredients
- BETAMETHASONE 0.1 PER
- FUSIDIC ACID 2 PER